Drug recall · March 24, 2021
Phenylephrine HCl Injection recall
Why: Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial packaged in 25 x 1 mL Single-Dose Vials per carton, For Intravenous Use, Rx only, Mfd. for: SAGENT Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC: 25021-315-01.
- Lots / codes
Lots: PHT8IB2, PHT9IB2, exp 08/2022; PHT1JB2, exp 09/2022
- Quantity
- 3716 cartons
- Company
- Sagent Pharmaceuticals Inc, Schaumburg, IL
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- March 11, 2021 · Voluntary: Firm initiated
- Classified
- March 17, 2021
- Reported
- March 24, 2021
- Ended
- December 28, 2022
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Phenylephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.